The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size

Sae-Byeol Choi, Kyung Sik Kim, Young Nyun Park, Jin Sub Choi, Woo Jung Lee, Jinsil Seong, Kwang Hyub Han, Jong Tae Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In cases of large hepatocellular carcinoma (HCC), neoadjuvant treatment such as transarterial chemoembolization (TACE) and radiation therapy can be performed. The aim of this study was to evaluate the outcome of these treatments prior to hepatic resection. Between January 1994 and May 2007, 16 patients with HCC greater than 5 cm in size were treated with TACE and radiation therapy prior to hepatic resection. The clinicopathologic factors were reviewed retrospectively. Of the 16 patients, there were 14 men and two women, and the median age was 52.5 yr. TACE was performed three times in average, and the median radiation dosage was 45 Gy. The median diameter of tumor on specimen was 9.0 cm. The degree of tumor necrosis was more than 90% in 14 patients. The median survival time was 13.3 months. Five patients had survived more than 2 yr and there were two patients who had survived more than 5 yr. Although the prognosis of large HCC treated with neoadjuvant therapy is not satisfactory, some showed long-term survival loger than 5 yr. Further research will be required to examine the survival and disease control effect in a prospective randomized study.

Original languageEnglish
Pages (from-to)242-247
Number of pages6
JournalJournal of Korean Medical Science
Volume24
Issue number2
DOIs
Publication statusPublished - 2009 Apr 1
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Radiotherapy
Liver
Neoadjuvant Therapy
Survival
Radiation Dosage
Neoplasms
Necrosis
Prospective Studies
Research

Keywords

  • Carcinoma, Hepatocellular
  • Hepatic Resection
  • Radiotherapy
  • TACE

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. / Choi, Sae-Byeol; Kim, Kyung Sik; Park, Young Nyun; Choi, Jin Sub; Lee, Woo Jung; Seong, Jinsil; Han, Kwang Hyub; Lee, Jong Tae.

In: Journal of Korean Medical Science, Vol. 24, No. 2, 01.04.2009, p. 242-247.

Research output: Contribution to journalArticle

Choi, Sae-Byeol ; Kim, Kyung Sik ; Park, Young Nyun ; Choi, Jin Sub ; Lee, Woo Jung ; Seong, Jinsil ; Han, Kwang Hyub ; Lee, Jong Tae. / The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. In: Journal of Korean Medical Science. 2009 ; Vol. 24, No. 2. pp. 242-247.
@article{b273df94eceb49f385e5b3cea3e859b7,
title = "The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size",
abstract = "In cases of large hepatocellular carcinoma (HCC), neoadjuvant treatment such as transarterial chemoembolization (TACE) and radiation therapy can be performed. The aim of this study was to evaluate the outcome of these treatments prior to hepatic resection. Between January 1994 and May 2007, 16 patients with HCC greater than 5 cm in size were treated with TACE and radiation therapy prior to hepatic resection. The clinicopathologic factors were reviewed retrospectively. Of the 16 patients, there were 14 men and two women, and the median age was 52.5 yr. TACE was performed three times in average, and the median radiation dosage was 45 Gy. The median diameter of tumor on specimen was 9.0 cm. The degree of tumor necrosis was more than 90{\%} in 14 patients. The median survival time was 13.3 months. Five patients had survived more than 2 yr and there were two patients who had survived more than 5 yr. Although the prognosis of large HCC treated with neoadjuvant therapy is not satisfactory, some showed long-term survival loger than 5 yr. Further research will be required to examine the survival and disease control effect in a prospective randomized study.",
keywords = "Carcinoma, Hepatocellular, Hepatic Resection, Radiotherapy, TACE",
author = "Sae-Byeol Choi and Kim, {Kyung Sik} and Park, {Young Nyun} and Choi, {Jin Sub} and Lee, {Woo Jung} and Jinsil Seong and Han, {Kwang Hyub} and Lee, {Jong Tae}",
year = "2009",
month = "4",
day = "1",
doi = "10.3346/jkms.2009.24.2.242",
language = "English",
volume = "24",
pages = "242--247",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

TY - JOUR

T1 - The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size

AU - Choi, Sae-Byeol

AU - Kim, Kyung Sik

AU - Park, Young Nyun

AU - Choi, Jin Sub

AU - Lee, Woo Jung

AU - Seong, Jinsil

AU - Han, Kwang Hyub

AU - Lee, Jong Tae

PY - 2009/4/1

Y1 - 2009/4/1

N2 - In cases of large hepatocellular carcinoma (HCC), neoadjuvant treatment such as transarterial chemoembolization (TACE) and radiation therapy can be performed. The aim of this study was to evaluate the outcome of these treatments prior to hepatic resection. Between January 1994 and May 2007, 16 patients with HCC greater than 5 cm in size were treated with TACE and radiation therapy prior to hepatic resection. The clinicopathologic factors were reviewed retrospectively. Of the 16 patients, there were 14 men and two women, and the median age was 52.5 yr. TACE was performed three times in average, and the median radiation dosage was 45 Gy. The median diameter of tumor on specimen was 9.0 cm. The degree of tumor necrosis was more than 90% in 14 patients. The median survival time was 13.3 months. Five patients had survived more than 2 yr and there were two patients who had survived more than 5 yr. Although the prognosis of large HCC treated with neoadjuvant therapy is not satisfactory, some showed long-term survival loger than 5 yr. Further research will be required to examine the survival and disease control effect in a prospective randomized study.

AB - In cases of large hepatocellular carcinoma (HCC), neoadjuvant treatment such as transarterial chemoembolization (TACE) and radiation therapy can be performed. The aim of this study was to evaluate the outcome of these treatments prior to hepatic resection. Between January 1994 and May 2007, 16 patients with HCC greater than 5 cm in size were treated with TACE and radiation therapy prior to hepatic resection. The clinicopathologic factors were reviewed retrospectively. Of the 16 patients, there were 14 men and two women, and the median age was 52.5 yr. TACE was performed three times in average, and the median radiation dosage was 45 Gy. The median diameter of tumor on specimen was 9.0 cm. The degree of tumor necrosis was more than 90% in 14 patients. The median survival time was 13.3 months. Five patients had survived more than 2 yr and there were two patients who had survived more than 5 yr. Although the prognosis of large HCC treated with neoadjuvant therapy is not satisfactory, some showed long-term survival loger than 5 yr. Further research will be required to examine the survival and disease control effect in a prospective randomized study.

KW - Carcinoma, Hepatocellular

KW - Hepatic Resection

KW - Radiotherapy

KW - TACE

UR - http://www.scopus.com/inward/record.url?scp=67650369851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650369851&partnerID=8YFLogxK

U2 - 10.3346/jkms.2009.24.2.242

DO - 10.3346/jkms.2009.24.2.242

M3 - Article

VL - 24

SP - 242

EP - 247

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -